Ohio Innovation Fund

Ohio Innovation Fund, established in 2016 and headquartered in Columbus, Ohio, is a venture capital firm focusing on early-stage investments. It partners with visionary founders to support the growth of disruptive companies, primarily in the technology sector. The firm's investment focus spans across medical technology, biopharma, AR/VR, advanced manufacturing, SaaS, AI/ML, cybersecurity, and mobility. Typically investing between $250,000 to $500,000 initially, with follow-on investments up to $1.25 million based on milestones, Ohio Innovation Fund aims to foster innovation and create industries of the future within the United States, with a particular emphasis on Ohio-based startups.

Bill Baumel

Managing Director

Michael Hughes

Venture Partner

Jill Raderstorf

Partner

Faith Voinovich

Principal

39 past transactions

Niobium Microsystems

Seed Round in 2024
Niobium Microsystems specializes in designing custom integrated circuits and microelectronic systems tailored to meet complex power, performance, and security requirements of its clients. The company focuses on developing high-performance microelectronic components that facilitate secure data collection, processing, and distribution. Notably, Niobium has developed a complete System-on-Chip (SoC) design for fully homomorphic encryption (FHE), offering semiconductor solutions that prioritize data security for its clients.

Trace

Pre Seed Round in 2024
Trace is the Canva for AR. The simplest way ever to make AR recordings and experiences for brands, retail, training and more. Partners include teams at Qualcomm, Deutsche Telekom, Lenovo, Telefonica and other fortune 500 companies. Contact us to work together or learn more. Info@Trace3d.app

Clarametyx Biosciences

Series A in 2024
Clarametyx Biosciences, Inc. is a biotechnology company founded in 2020 and headquartered in Columbus, Ohio. The company focuses on developing targeted and immune-enabling biologic therapies that address persistent infections associated with biofilms, which are protective layers that shield bacteria and complicate treatment. Clarametyx has created a novel technology platform that allows for the targeting of these biofilms, thereby enhancing immune response and facilitating antibiotic intervention. One of its key products in development is CMTX-001, a humanized monoclonal antibody currently in the late preclinical stage, aimed at treating hospital-acquired pneumonia. Clarametyx Biosciences is dedicated to combating life-threatening infections and reducing antibiotic resistance through its innovative therapeutic solutions.

Lentechs

Venture Round in 2023
Lentechs is a medical device company based in Columbus, Ohio, specializing in the development of innovative soft bifocal contact lenses. The company focuses on creating a new generation of soft, suspended progressive contact lenses that enhance user experience by allowing natural eye movement, similar to that achieved with traditional bifocal glasses. This design aims to provide improved comfort and visual clarity, enabling users to see freely without discomfort. Lentechs is dedicated to addressing the needs of patients throughout their lifecycle, ensuring that its products offer both functionality and ease of use.

AKRU

Seed Round in 2022
AKRU operates a blockchain-based commercial real estate investment platform that enables fractional ownership through security tokens, starting at $1,000. The platform facilitates instantaneous transactions recorded on an immutable ledger, enhancing transparency and investor trust. Since its paid beta launch in 2020, AKRU has secured 14 assets and over 50 investors, demonstrating market traction.

Genetesis

Series C in 2022
Genetesis LLC, established in 2013 and based in Mason, Ohio, specializes in designing, developing, and providing biomagnetic imaging solutions for cardiac healthcare. The company's primary product is Genetesis CardioFlux, a mapping system that optimizes the detection, characterization, and treatment of cardiac rhythm disorders by visualizing electrical currents of the heart in 3D. Additionally, they offer Faraday Analytical Cloud, a HIPAA-compliant platform managing end-to-end data workflow for their Magnetocardiograph (MCG). Genetesis aims to redefine clinical diagnosis, monitoring, and screening processes for patients at risk of myocardial ischemia and coronary artery disease, using non-invasive, radiation-free methods.

Enable Injections

Series C in 2022
Enable Injections, LLC is a company based in Cincinnati, Ohio, that specializes in developing wearable drug delivery devices designed for the subcutaneous administration of high-viscosity and high-volume therapeutics. Founded in 2010, Enable Injections produces a disposable bolus injector that can deliver up to 20 ml of medication directly from standard containers such as vials, syringes, or cartridges. Their innovative system allows for the automatic warming and mixing of lyophilized solutions, facilitating the reconstitution of powdered drugs into liquids before injection. The device features a user-friendly interface, enabling easy operation with a central button and a viewing window for monitoring progress. Additionally, Enable Injections offers partial or multi-vial transfer systems and a Bluetooth-enabled version for smartphone connectivity, positioning itself uniquely in the market for drug delivery solutions. The company aims to meet the growing demand for advanced injection technologies as the pharmaceutical industry develops new therapies requiring bolus injection methods.

Aware

Series C in 2021
Aware is a cloud intelligence platform that leverages advancements in cognitive computing, artificial intelligence, and behavioral analytics to enhance enterprise value through social graph monitoring. The company provides governance, compliance, and monitoring solutions aimed at improving connectivity, collaboration, and security within organizations. Their platform addresses challenges faced by legal, compliance, information security, and IT departments, offering tools for archiving, monitoring, organizational insights, data loss prevention, eDiscovery, retention, and legal holds. By harnessing insights into human behavior and interactivity, Aware aims to improve employee engagement while minimizing the risk of unsafe behavior in the workplace.

DAtAnchor

Convertible Note in 2021
Traditional IT controls focus on locking down networks, devices, and people. All of this is done in the name of protecting data. But, once files are moved, shared, or stolen, the data is no longer protected. Even worse, these controls get in the way and frustrate business users to the point they intentionally work around them. Anchor inverts the equation by baking protection into the data, invisible to the business users (like antivirus), so that files are free to travel and security is out of the way. Simply put, wherever the data goes, it is protected. Anchor is a SaaS platform, with an endpoint component, that bakes protection into your files with a unique transparent combination of encryption, continuous multi-factor access controls, and a digital chain of custody. And when you do share or collaborate, Anchor protection stays with your data, even when it leaves your organization. Anchor empowers you to maintain control of your files while collaborating on premise or in the cloud, including forensic logging and revoking access. In under 90 minutes, Anchor is fully deployed and empowers your business users to securely work and collaborate without complicated security products or rules in the way. All without requiring you to change existing IT controls or how your users and applications work today. DAtAnchor is a result of a multi-year research activity, developed at Ohio State University. The development team currently has 6 members, 4 of which are full-time. We have seed level funding for >1M and an advisory board with members at the senior vice president level in Fortune 500 companies.

S4 Medical

Series A in 2021
S4 Medical Corp is a medical device company specializing in innovations for catheter ablation treatment of atrial fibrillation. Founded in 2017 and based in Cleveland, Ohio, S4 Medical has developed an eSolution device that aims to reduce complications to the esophagus during ablation procedures. This device provides an effective means for electrophysiologists to protect the esophagus and strategically determine when and where to deviate it, thereby minimizing the risk of thermal injury associated with these cardiac interventions. The company's focus on enhancing safety during atrial fibrillation treatments underscores its commitment to improving patient outcomes in the field of cardiology.

eFuse

Venture Round in 2021
eFuse is a web and mobile application focused on the esports and video game industry, founded in 2018 and based in Columbus, Ohio. The platform aims to unify the gaming community by serving as a central hub for various collaborations and opportunities. Users can establish their gaming identities while accessing resources for learning about the industry, networking with peers, and finding job placements or scholarships. eFuse facilitates player talent recruitment and the sourcing of sponsorship deals, catering to individuals at all levels of engagement in the gaming sector. Through its comprehensive offerings, eFuse enhances the experience for game enthusiasts and fosters connections within the gaming ecosystem.

Aware

Series B in 2020
Aware is a cloud intelligence platform that leverages advancements in cognitive computing, artificial intelligence, and behavioral analytics to enhance enterprise value through social graph monitoring. The company provides governance, compliance, and monitoring solutions aimed at improving connectivity, collaboration, and security within organizations. Their platform addresses challenges faced by legal, compliance, information security, and IT departments, offering tools for archiving, monitoring, organizational insights, data loss prevention, eDiscovery, retention, and legal holds. By harnessing insights into human behavior and interactivity, Aware aims to improve employee engagement while minimizing the risk of unsafe behavior in the workplace.

ScriptDrop

Series A in 2020
ScriptDrop operates a prescription delivery platform that connects patients with pharmacies across all 50 U.S. states. Founded in 2016 and based in Columbus, Ohio, the company uses predictive algorithms to facilitate deliveries based on patient needs, thereby streamlining workflows for pharmacists while enhancing medication adherence for patients.

Immuta

Series C in 2020
Immuta, Inc. is a data security company that specializes in providing organizations with a platform for managing data privacy, security, and access control. The Immuta Data Security Platform enables users to discover and classify sensitive data, implement access control policies, and monitor data usage without the need for coding. This automated data governance solution supports self-service access to data while ensuring compliance with various regulations. Immuta is utilized by a diverse range of industries, including finance, healthcare, government, and manufacturing, to facilitate cloud migration and secure collaboration. Founded in 2014 and headquartered in College Park, Maryland, with additional offices in Boston, Massachusetts and Columbus, Ohio, Immuta has established itself as a trusted partner for Fortune 500 companies and government agencies worldwide.

Genetesis

Series B in 2020
Genetesis LLC, established in 2013 and based in Mason, Ohio, specializes in designing, developing, and providing biomagnetic imaging solutions for cardiac healthcare. The company's primary product is Genetesis CardioFlux, a mapping system that optimizes the detection, characterization, and treatment of cardiac rhythm disorders by visualizing electrical currents of the heart in 3D. Additionally, they offer Faraday Analytical Cloud, a HIPAA-compliant platform managing end-to-end data workflow for their Magnetocardiograph (MCG). Genetesis aims to redefine clinical diagnosis, monitoring, and screening processes for patients at risk of myocardial ischemia and coronary artery disease, using non-invasive, radiation-free methods.

S4 Medical

Venture Round in 2020
S4 Medical Corp is a medical device company specializing in innovations for catheter ablation treatment of atrial fibrillation. Founded in 2017 and based in Cleveland, Ohio, S4 Medical has developed an eSolution device that aims to reduce complications to the esophagus during ablation procedures. This device provides an effective means for electrophysiologists to protect the esophagus and strategically determine when and where to deviate it, thereby minimizing the risk of thermal injury associated with these cardiac interventions. The company's focus on enhancing safety during atrial fibrillation treatments underscores its commitment to improving patient outcomes in the field of cardiology.

Able (formerly EmployStream)

Series B in 2020
EmployStream is a hiring workflow automation software platform for staffing companies and other high-volume employers. It also creates high-quality, user-friendly for high-volume employers that automates the hiring and onboarding process for employers. The platform eliminates costly mistakes and delays allowing companies to hire up to 90% faster and at half the cost. The company provides an online hiring platform which offers different features such as paper onboarding, real-time alerting, online application, background checks, applicant pre & interview screening, and verification. EmployStream was founded in 2014 and is headquartered in Cleveland Ohio, USA.

Windpact

Venture Round in 2019
Windpact, Inc. is a company that specializes in impact protection solutions for various sectors, including sports, military, automotive, construction, and medical applications. Founded in 2011 and headquartered in Leesburg, Virginia, Windpact offers platform as a service solutions that assist product development teams in exploring advanced foam technologies. The company utilizes refined machine learning principles, finite element analysis modeling, and an innovative Crash Cloud system, which adapts to manage diverse impact rates, ensuring safety for individuals exposed to potential impacts. Additionally, Windpact provides software tools that support product developers throughout their growth stages, featuring capabilities such as parts analysis, design optimization, and three-dimensional manufacturing, ultimately aiming to enhance performance while reducing development costs and timelines.

eFuse

Seed Round in 2019
eFuse is a web and mobile application focused on the esports and video game industry, founded in 2018 and based in Columbus, Ohio. The platform aims to unify the gaming community by serving as a central hub for various collaborations and opportunities. Users can establish their gaming identities while accessing resources for learning about the industry, networking with peers, and finding job placements or scholarships. eFuse facilitates player talent recruitment and the sourcing of sponsorship deals, catering to individuals at all levels of engagement in the gaming sector. Through its comprehensive offerings, eFuse enhances the experience for game enthusiasts and fosters connections within the gaming ecosystem.

Able (formerly EmployStream)

Series A in 2019
EmployStream is a hiring workflow automation software platform for staffing companies and other high-volume employers. It also creates high-quality, user-friendly for high-volume employers that automates the hiring and onboarding process for employers. The platform eliminates costly mistakes and delays allowing companies to hire up to 90% faster and at half the cost. The company provides an online hiring platform which offers different features such as paper onboarding, real-time alerting, online application, background checks, applicant pre & interview screening, and verification. EmployStream was founded in 2014 and is headquartered in Cleveland Ohio, USA.

Complion

Series B in 2019
Complion Inc. is a developer of a web-based document and workflow management platform tailored for clinical research sites, academic medical centers, hospitals, health systems, and sponsors. The platform enables secure and compliant management of regulatory documents and administrative tasks, featuring tools for document tracking, patient record organization, e-signatures, and real-time compliance insights. It also supports the coordination of multi-center trials, facilitates study startup and closeout processes, and assists with safety reporting and regulatory compliance. Complion offers customer service, training, and a comprehensive online help center, along with customizable training materials. The platform enhances efficiency for administrators and research coordinators while providing essential information to auditors and quality assurance personnel. Founded in 2012 and headquartered in Cleveland, Ohio, Complion was previously known as RegBinder, Inc. before its name change in December 2013.

Stirling Ultracold

Series B in 2018
Stirling Ultracold, a division of Global Cooling, Inc., specializes in the development and manufacturing of environmentally friendly ultra-low temperature freezers that operate below -86°C. These innovative freezers utilize patented free-piston Stirling engine technology, distinguishing them from traditional cooling methods that rely on dry ice or conventional cascade refrigeration systems. Stirling Ultracold's products are designed to meet the increasing demands of bio-repositories and pharmaceutical companies, providing stable storage conditions across a wide temperature range. This technology not only enables significant energy savings but also promotes true environmental sustainability in the field of ultra-low temperature storage solutions.

DAtAnchor

Seed Round in 2018
Traditional IT controls focus on locking down networks, devices, and people. All of this is done in the name of protecting data. But, once files are moved, shared, or stolen, the data is no longer protected. Even worse, these controls get in the way and frustrate business users to the point they intentionally work around them. Anchor inverts the equation by baking protection into the data, invisible to the business users (like antivirus), so that files are free to travel and security is out of the way. Simply put, wherever the data goes, it is protected. Anchor is a SaaS platform, with an endpoint component, that bakes protection into your files with a unique transparent combination of encryption, continuous multi-factor access controls, and a digital chain of custody. And when you do share or collaborate, Anchor protection stays with your data, even when it leaves your organization. Anchor empowers you to maintain control of your files while collaborating on premise or in the cloud, including forensic logging and revoking access. In under 90 minutes, Anchor is fully deployed and empowers your business users to securely work and collaborate without complicated security products or rules in the way. All without requiring you to change existing IT controls or how your users and applications work today. DAtAnchor is a result of a multi-year research activity, developed at Ohio State University. The development team currently has 6 members, 4 of which are full-time. We have seed level funding for >1M and an advisory board with members at the senior vice president level in Fortune 500 companies.

Enable Injections

Series B in 2018
Enable Injections, LLC is a company based in Cincinnati, Ohio, that specializes in developing wearable drug delivery devices designed for the subcutaneous administration of high-viscosity and high-volume therapeutics. Founded in 2010, Enable Injections produces a disposable bolus injector that can deliver up to 20 ml of medication directly from standard containers such as vials, syringes, or cartridges. Their innovative system allows for the automatic warming and mixing of lyophilized solutions, facilitating the reconstitution of powdered drugs into liquids before injection. The device features a user-friendly interface, enabling easy operation with a central button and a viewing window for monitoring progress. Additionally, Enable Injections offers partial or multi-vial transfer systems and a Bluetooth-enabled version for smartphone connectivity, positioning itself uniquely in the market for drug delivery solutions. The company aims to meet the growing demand for advanced injection technologies as the pharmaceutical industry develops new therapies requiring bolus injection methods.

Alviere

Series A in 2018
Alviere is a financial technology company that specializes in providing an embedded finance platform, enabling brands to offer a range of financial services directly to their customers. Its platform facilitates the delivery of various financial products, including banking services, mobile payments, card issuance, payment processing, and cross-border currency exchange. By streamlining and automating these offerings, Alviere helps businesses enhance customer relationships, boost revenue, and improve overall profitability. The company's flexible framework allows clients to easily launch new financial service lines, thereby increasing customer satisfaction and retention while gaining valuable insights into consumer behavior.

RXQ Compounding

Series A in 2018
RXQ Compounding, LLC is a manufacturer and distributor of sterile and non-sterile medications based in Athens, Ohio. Founded in 2014, the company operates as an FDA approved 503B Outsourcing Facility and offers a diverse range of products, including injectable medications, veterinary treatments, dermatologic creams, ophthalmic solutions, orthopedic steroids, and custom compounding services for hospitals. RXQ Compounding emphasizes safety and quality by adhering to stringent procedural standards, ensuring that its products meet regulatory requirements. The company markets its offerings online, aiming to provide healthcare providers with reliable access to compounded drugs and minimize delivery times for optimal patient outcomes. Through its partnership with the Ohio University Innovation Center, RXQ Compounding seeks to become a leader in the evolving landscape of pharmaceutical manufacturing.

Eccrine Systems

Series B in 2018
Eccrine Systems, Inc. is a Cincinnati-based company that specializes in developing and commercializing non-invasive electronic wearable systems for measuring and transmitting real-time data about human sweat. Founded in 2013, the company offers the Sweatronics platform, a modular wearables system designed to analyze multiple analytes in sweat and wirelessly transmit data to remote applications. Eccrine Systems' advanced sweat sensor technologies serve a variety of sectors, including medicine, industry, and sports, enabling the monitoring of sweat biomarkers with chronological accuracy. This capability allows for significant improvements in the predictive value of wearables, aiding in the assessment of hydration levels, health conditions, and the effectiveness of medications. Through collaborations with downstream partners, Eccrine Systems aims to translate its foundational technology into market-leading products and solutions tailored to specific application needs.

Mezu

Venture Round in 2018
Mezu, Inc. is a banking technology company based in Cleveland Heights, Ohio, incorporated in 2017. It operates a mobile payment application that enables users to send and receive money privately and securely, without the need to share personal information. The app facilitates cash-like transactions, allowing users to pay, tip, earn, and donate without incurring fees. Available on both iOS and Android platforms in the United States, Mezu prioritizes user privacy, emphasizing that financial activities should remain confidential.

Genetesis

Series A in 2018
Genetesis LLC, established in 2013 and based in Mason, Ohio, specializes in designing, developing, and providing biomagnetic imaging solutions for cardiac healthcare. The company's primary product is Genetesis CardioFlux, a mapping system that optimizes the detection, characterization, and treatment of cardiac rhythm disorders by visualizing electrical currents of the heart in 3D. Additionally, they offer Faraday Analytical Cloud, a HIPAA-compliant platform managing end-to-end data workflow for their Magnetocardiograph (MCG). Genetesis aims to redefine clinical diagnosis, monitoring, and screening processes for patients at risk of myocardial ischemia and coronary artery disease, using non-invasive, radiation-free methods.

Immuta

Series B in 2018
Immuta, Inc. is a data security company that specializes in providing organizations with a platform for managing data privacy, security, and access control. The Immuta Data Security Platform enables users to discover and classify sensitive data, implement access control policies, and monitor data usage without the need for coding. This automated data governance solution supports self-service access to data while ensuring compliance with various regulations. Immuta is utilized by a diverse range of industries, including finance, healthcare, government, and manufacturing, to facilitate cloud migration and secure collaboration. Founded in 2014 and headquartered in College Park, Maryland, with additional offices in Boston, Massachusetts and Columbus, Ohio, Immuta has established itself as a trusted partner for Fortune 500 companies and government agencies worldwide.

ConnXus

Series A in 2018
ConnXus, Inc. is a provider of online services that facilitate connections between diverse and small businesses and larger companies seeking to enhance their supplier diversity. Based in Mason, Ohio, with a satellite office in Portland, Oregon, ConnXus focuses on streamlining corporate purchasing by enabling organizations to find, evaluate, and engage performance-rated small, minority, and woman-owned businesses across various sectors, including construction, transportation, and information technology. The company offers several tools, including ConnXus Scrub, which enriches supplier data, and TierTracker, a platform for reporting and management of supplier diversity initiatives. Additionally, ConnXus provides a marketplace that allows users to network and exchange best practices among supplier diversity professionals. The firm supports registered suppliers in marketing their services and maintaining current certifications. ConnXus serves a range of clients, including Fortune 2000 and Fortune 500 companies, and is certified as a minority-owned business enterprise by several organizations.

Aware

Series A in 2018
Aware is a cloud intelligence platform that leverages advancements in cognitive computing, artificial intelligence, and behavioral analytics to enhance enterprise value through social graph monitoring. The company provides governance, compliance, and monitoring solutions aimed at improving connectivity, collaboration, and security within organizations. Their platform addresses challenges faced by legal, compliance, information security, and IT departments, offering tools for archiving, monitoring, organizational insights, data loss prevention, eDiscovery, retention, and legal holds. By harnessing insights into human behavior and interactivity, Aware aims to improve employee engagement while minimizing the risk of unsafe behavior in the workplace.

Immuta

Series A in 2017
Immuta, Inc. is a data security company that specializes in providing organizations with a platform for managing data privacy, security, and access control. The Immuta Data Security Platform enables users to discover and classify sensitive data, implement access control policies, and monitor data usage without the need for coding. This automated data governance solution supports self-service access to data while ensuring compliance with various regulations. Immuta is utilized by a diverse range of industries, including finance, healthcare, government, and manufacturing, to facilitate cloud migration and secure collaboration. Founded in 2014 and headquartered in College Park, Maryland, with additional offices in Boston, Massachusetts and Columbus, Ohio, Immuta has established itself as a trusted partner for Fortune 500 companies and government agencies worldwide.

Aware

Series A in 2017
Aware is a cloud intelligence platform that leverages advancements in cognitive computing, artificial intelligence, and behavioral analytics to enhance enterprise value through social graph monitoring. The company provides governance, compliance, and monitoring solutions aimed at improving connectivity, collaboration, and security within organizations. Their platform addresses challenges faced by legal, compliance, information security, and IT departments, offering tools for archiving, monitoring, organizational insights, data loss prevention, eDiscovery, retention, and legal holds. By harnessing insights into human behavior and interactivity, Aware aims to improve employee engagement while minimizing the risk of unsafe behavior in the workplace.

Aware

Series A in 2017
Aware is a cloud intelligence platform that leverages advancements in cognitive computing, artificial intelligence, and behavioral analytics to enhance enterprise value through social graph monitoring. The company provides governance, compliance, and monitoring solutions aimed at improving connectivity, collaboration, and security within organizations. Their platform addresses challenges faced by legal, compliance, information security, and IT departments, offering tools for archiving, monitoring, organizational insights, data loss prevention, eDiscovery, retention, and legal holds. By harnessing insights into human behavior and interactivity, Aware aims to improve employee engagement while minimizing the risk of unsafe behavior in the workplace.

Enable Injections

Series A in 2016
Enable Injections, LLC is a company based in Cincinnati, Ohio, that specializes in developing wearable drug delivery devices designed for the subcutaneous administration of high-viscosity and high-volume therapeutics. Founded in 2010, Enable Injections produces a disposable bolus injector that can deliver up to 20 ml of medication directly from standard containers such as vials, syringes, or cartridges. Their innovative system allows for the automatic warming and mixing of lyophilized solutions, facilitating the reconstitution of powdered drugs into liquids before injection. The device features a user-friendly interface, enabling easy operation with a central button and a viewing window for monitoring progress. Additionally, Enable Injections offers partial or multi-vial transfer systems and a Bluetooth-enabled version for smartphone connectivity, positioning itself uniquely in the market for drug delivery solutions. The company aims to meet the growing demand for advanced injection technologies as the pharmaceutical industry develops new therapies requiring bolus injection methods.

Spirosure

Series C in 2016
Spirosure is a company focused on the development and commercialization of breath-analysis devices designed for the non-invasive diagnosis and management of chronic diseases, including asthma, chronic obstructive pulmonary disease (COPD), and pulmonary hypertension. By leveraging advanced consumer technologies, such as sensors and algorithms, Spirosure's products enable medical researchers to detect biomarkers in a patient's breath. This capability allows for improved diagnosis and monitoring of respiratory conditions, as well as adherence to asthma-maintenance medications. The company's innovative approach positions it at the forefront of preventative healthcare, providing significant benefits to patients and healthcare providers alike.

DOmedia

Series A in 2016
DOmedia, LLC is an independent technology company based in Columbus, Ohio, that operates a media buying and selling platform focused on out-of-home media. Founded in 2007, the company provides cloud-based applications that facilitate the management of media information, proposal requests, and vendor interactions. Its online marketplace allows media providers to create profiles for their properties, while advertisers and agencies can access a comprehensive database to discover new ideas and efficiently plan out-of-home campaigns. By connecting buyers and sellers, DOmedia aims to streamline processes, reduce labor, and enhance reporting and analytics for agencies, vendors, and brands globally.

DecisionDesk

Debt Financing in 2013
DecisionDesk Inc. is a technology company specializing in application and enrollment management solutions tailored for higher education institutions, fine arts programs, and non-profits. Founded in 2008 and based in Lakewood, Ohio, DecisionDesk streamlines the admissions process through an intuitive platform that facilitates submission, review, and decision-making. The company's offerings include a comprehensive suite of tools such as application management, student dashboards, communication tools, mobile review capabilities, and reporting features. DecisionDesk's solutions encompass an end-to-end admissions system, with functionalities designed to simplify multi-stage evaluation processes and integrate seamlessly with existing campus systems, CRM, and SIS platforms. Additionally, it supports the submission of various digital application materials, including portfolios and video profiles, enhancing the efficiency of admissions workflows. Formerly known as CitizenGroove, Inc., DecisionDesk aims to save institutions time and resources while improving the overall admissions experience.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.